Home  >  TopNews
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
  Israel’s less stringent IP laws help create conducive business environment for Indian generic players: Experts,   September 25, 2023
  DBT brings out Intellectual Property Guidelines, 2023 for commercialisation of IP,   September 16, 2023
  Patient groups and public health experts raise concern over draft amendment on Patents Act,   September 15, 2023
  Delhi High Court rejects applications filed by Cadila Healthcare and Hetero Drugs against Roche's suit,   September 14, 2023
  No statutory mandate in Trade Mark Act that restricts trade mark infringement suite to specific HC: Delhi HC,   September 13, 2023
  Civil society groups ask UK govt to drop demands for stricter IP provisions as part of trade deal with India,   September 02, 2023
  Delhi HC order strengthens Glenmark's position in trademark dispute with Sun Pharma,   August 24, 2023
  Experts stress on need to combat patent thickets & product hopping in US market through policy interventions,   July 27, 2023
  Delhi HC refuses to grant interim injunction in favour of Bayer Healthcare in patent dispute over regorafenib,   July 11, 2023
  Zydus Wellness receives favourable order from Delhi HC on a trademark dispute against Cipla Health,   July 07, 2023
  ICMR invites applications for subscription based online IP management software to manage complete IP life cycle,   June 30, 2023
  Origiin IP sees Unitary Patent System in EU bringing benefits of cost, ease of filing for Indian pharma,   June 12, 2023
  Vifor sues Cipla & J B Chem for alleged infringement of patent of its iron carbohydrate drug,   May 08, 2023
  Novartis gets Indian patent for NLRP3 Inflammasome inhibitors,   May 04, 2023
  SCTIMST bags patent for improved stent for use in blood vessel with enhanced fixation,   April 22, 2023
  Industry sees Chennai HC with dedicated IPD to clear pharma innovation cases earliest,   April 14, 2023
  BMS enters into amicable settlement with two companies in Apixaban patent dispute,   April 13, 2023
  NPPA refers industry representation on 50% price cut on patented components to MDC,   April 08, 2023
  Delhi HC refuses interim injunction to Boehringer Ingelheim, permits generic manufacturers to produce linagliptin,   April 01, 2023
  Patent office refuses review petition of Sun Pharma for its anti-dengue botanical drug,   March 10, 2023

Pharma live expo
Copyright © 2023 Saffron Media Pvt. Ltd |